The global mammography market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Mammography refers to a non-invasive medical imaging and diagnostic procedure that uses low-dose X-rays to screen breast tissues for malignant tumor cells. A mammography exam, or mammogram, uses analog, digital, computer-aided detection and tomosynthesis systems to highlight small tumors, cysts and other irregularities in the breasts. Screening mammography is conducted to check for abnormalities in the absence of any symptoms, which can aid in timely treatment of a serious medical condition. It is usually followed by a diagnostic mammogram to evaluate any abnormal clinical findings. As a result, it finds extensive applications in hospitals, specialty clinics and diagnostic and ambulatory surgical centers.
The increasing prevalence of breast cancer across the globe is one of the key factors driving the growth of the market. Moreover, increasing awareness regarding the available treatment alternatives and the benefits of screening and early diagnosis of breast cancer among the masses is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative 3-Dimentional, non-ionizing and ionizing imaging solutions, are acting as other growth-inducing factors. For instance, Full-field digital mammography (FFDM) and Digital Breast Tomosynthesis (DBT) systems capture numerous images of the breast from multiple angles and integrates them into a 3D image set for the generation of results with enhanced precision. In line with this, the availability of rental services for digital mammography systems for public hospitals and diagnostic centers providing cost-effective imaging solutions is also contributing to the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mammography market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology and product.
Breakup by Technology:
Breakup by Product:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Analogic Corporation, Carestream Health (Onex Corporation), Fujifilm Holdings Corporation, General Electric Company, Hologic Inc., Konica Minolta Inc., Metaltronica S.p.A., Mindray Medical International Limited, Koninklijke Philips N.V., Planmed Oy (Planmeca Oy) and Siemens AG.
|Base Year of the Analysis||2020|
|Segment Coverage||Technology, Product, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Analogic Corporation, Carestream Health (Onex Corporation), Fujifilm Holdings Corporation, General Electric Company, Hologic Inc., Konica Minolta Inc., Metaltronica S.p.A., Mindray Medical International Limited, Koninklijke Philips N.V., Planmed Oy (Planmeca Oy) and Siemens AG.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at